Research methods and emerging therapies for blood diseases, cancers and lymphomas, stem cell transplantation and CAR-T therapy, surviving cancer with art therapy and an overview of treatments and current research in chronic lymphocytic leukemia, acute leukemia and chronic myeloid leukemia, myeloproliferative disorders, lymphomas, Waldenstrom's macroglobulinemia, and multiple myeloma.
We invite patients, their families, friends, and caregivers to hear from nationally esteemed physicians about new scientific knowledge and advances. For patient safety, all attendees must be vaccinated and wear a mask. Attend at your own risk.
Presenters:
Ruemu Birhiray, Indy Hematology Education/Hematology Oncology of Indiana, PC (Indianapolis, IN)
Richard Childs, National Institutes of Health/National Heart, Lung, and Blood Institute (Bethesda, MD)
Meaghan Wiggins, Cancer Support Community (Carmel, IN)
Mesa Ruben, Mays Cancer Center at UT Health San Antonio (Boerne, TX)
Steven Treon, Dana-Farber Cancer Institute (Boston, MA)
Kenneth Anderson, Dana-Farber Cancer Institute (Boston, MA)
Adrian Wiestner, National Institutes of Health/National Heart, Lung, and Blood Institute (Bethesda, MD)
Richard Stone, Dana-Farber Cancer Institute; Harvard Medical School, (Boston, MA)
John Leonard, Weill Cornell Medicine (New York, NY)
Space is limited.
Parking: Available at the Westin Hotel and the Government Center garage.
You must register for this free program by September 1, 2022.
Questions? Contact 317-841-7171 or [email protected]
Discussion
By posting you agree to the Terms and Privacy Policy.